3 episodes

Life/ on air! a nephrology podcast series is part of the Life/ nephrology campus. Life/ nephrology campus is a medical-scientific educational program chaired by Prof. Dr. Christoph Wanner, University Hospital Würzburg, Germany, and Prof. Dr. Peter Stenvinkel, Karolinska Institutet Stockholm, Sweden, and is empowered by Fresenius Medical Care Deutschland GmbH. Providing a platform for international scientific exchange together with the world’s leading nephrologists, Life/ nephrology campus is dedicated to shaping the future of personalized patient care. The Life/ nephrology campus includes a series of 18 webinars, started on September 15, 2020 that led to the Life/2021 nephrology congress, which took place from September 15 – 18, 2021. Moreover, Life/ nephrology campus continuously enlarges its repertoire with new updates on current trends in local and international nephrology. You can still access all lectures recorded for the Life/ nephrology campus simply by creating your Life/account – giving you the opportunity to advance your knowledge at www.nephrologycampus.com. ------------- Imprint -------------Fresenius Medical Care Deutschland GmbH, Else-Kröner-Str. 1, 61352 Bad Homburg v.d.H., Germany, Registered office: Bad Homburg v.d.H., Registered court: Amtsgericht Bad Homburg v.d.H., HRB 5748, Management Board: Dr. Katarzyna Mazur-Hofsäß, Peter Palmqvist, Dr. Olaf Schermeier, Stefan Trappe, Turnover tax identification number: DE 812033564-------------------------------------

Life/ on air! a nephrology podcast series Fresenius Medical Care Deutschland GmbH

    • Health & Fitness

Life/ on air! a nephrology podcast series is part of the Life/ nephrology campus. Life/ nephrology campus is a medical-scientific educational program chaired by Prof. Dr. Christoph Wanner, University Hospital Würzburg, Germany, and Prof. Dr. Peter Stenvinkel, Karolinska Institutet Stockholm, Sweden, and is empowered by Fresenius Medical Care Deutschland GmbH. Providing a platform for international scientific exchange together with the world’s leading nephrologists, Life/ nephrology campus is dedicated to shaping the future of personalized patient care. The Life/ nephrology campus includes a series of 18 webinars, started on September 15, 2020 that led to the Life/2021 nephrology congress, which took place from September 15 – 18, 2021. Moreover, Life/ nephrology campus continuously enlarges its repertoire with new updates on current trends in local and international nephrology. You can still access all lectures recorded for the Life/ nephrology campus simply by creating your Life/account – giving you the opportunity to advance your knowledge at www.nephrologycampus.com. ------------- Imprint -------------Fresenius Medical Care Deutschland GmbH, Else-Kröner-Str. 1, 61352 Bad Homburg v.d.H., Germany, Registered office: Bad Homburg v.d.H., Registered court: Amtsgericht Bad Homburg v.d.H., HRB 5748, Management Board: Dr. Katarzyna Mazur-Hofsäß, Peter Palmqvist, Dr. Olaf Schermeier, Stefan Trappe, Turnover tax identification number: DE 812033564-------------------------------------

    Dr. Adam Zawada: Hemodialysis membranes and platelet loss

    Dr. Adam Zawada: Hemodialysis membranes and platelet loss

    Meet Dr. Adam Zawada at Life/ on air! In this episode, Dr. Zawada talks about polyvinylpyrrolidone as a new option for dialyzers that may improve biocompatibility for patients. He refers to study results from his recent publication (Zawada AM et al. 2021 Hemodial Int online) “Polyvinylpyrrolidone in hemodialysis membranes: Impact on platelet loss during hemodialysis”.
     
    Dr. Zawada worked as Research Scientist at Saarland University Medical Center, Germany. Today he is Research & Development Scientist Product Development at Fresenius Medical Care.

    • 5 min
    Prof. Dr. Bernard Canaud: How dialyzer innovations support attaining treatment goals

    Prof. Dr. Bernard Canaud: How dialyzer innovations support attaining treatment goals

    Meet Prof. Dr. Bernard Canaud at Life/ on air! In this episode, Prof. Dr. Canaud talks about how to improve clinical outcomes for patients undergoing dialysis. He will point out the changes that dialysis administration has gone through in recent years and the importance of complement activation and inflammation in the short term and long term for patient outcomes.
     
    He is currently an Emeritus Professor of Nephrology at Montpellier University School of Medicine, France, and is Senior Chief Scientist at Fresenius Medical Care. He was former president of the Association pour Installation à Domicile des Epurations Rénales (AIDER).

    • 5 min
    Prof. Dr. Andrew Davenport - Options for improving dialysis treatments and outcomes

    Prof. Dr. Andrew Davenport - Options for improving dialysis treatments and outcomes

    Meet Prof. Dr. Andrew Davenport at Life/ on air! He is President of the International Society for Hemodialysis and member of the ERA-EDTA Renal Nutrition board, and former vice-chair European Dialysis board. He is a Professor of Dialysis & ICU Nephrology, and director of the Dialysis & Renal Physiology center at University College London.
    In this episode, he talks about available options for improving dialysis treatments and outcomes and what biological factors can impact clinical choice. In the end, he will share his thoughts about how to improve current dialyzers.

    • 5 min

Top Podcasts In Health & Fitness

Huberman Lab
Scicomm Media
The School of Greatness
Lewis Howes
Passion Struck with John R. Miles
John R. Miles
On Purpose with Jay Shetty
iHeartPodcasts
Ten Percent Happier with Dan Harris
Ten Percent Happier
ZOE Science & Nutrition
ZOE